Get documents about "THE LONDON GAZETTE ra JANUARY
Document Sample
1668 THE LONDON GAZETTE, 29ra JANUARY 1993
Product Licence Company Product Active Indlcattmu Date of
Number Name Name Ingredlentt (Non-Prescription Items) Authorisation
PM
0339/0046 ScCBdfiRB Salve Resin (Colophony) BP 26% w/w Except POM cases: Indicated in 19th October
(t/a Fisons Consumer Health) Turpentine Oil BP 6% w/w the treatment of boils, minor skin 1992
Melaleuca Oil BPC1949 BPC 5-6% w/w infections.
Terebene 5-25% w/w GSL
Phenol BP 2-4% w/w
0339/0047 Radio! Chemicals Limited Caldesene Medicated Powder Calcium Undecyclenate 10-00% w/w Except POM cases: 19th October
(t/a Fisons Consumer Health, For the prevention and treatment 1992
Dublin) of local rashes of buttocks due to
friction and irritation including
prickly heat and chafing.
For the prophylaxis of nappy rash.
OSL
0339/0048 Radio! Chemicals Limited P3 Squeeze Powder Calcium Undecyclenate 10-00% w/w Except POM cases: As on adjunct 19th October
(t/a Fisons Consumer Health. to the treatment of jock-itch 1992
Dublin) fungus (tinea cruris—dhobie itch).
Absorbs perspiration.
OSL
0339/0049 Radiol Chemicals Limited Desenex Powder Zinc Undecenoate Ph Bur 20-0% w/w Except POM cases: For the 19th October
(t/a Fisons Consumer Health) Undeomoic Add Ph Bur 2-0% w/w prophylaxis and treatment of 1992
mycotic superficial
dermatophytoses of feet, axillae
and groin.
OSL
0339/0050 Radiol Chemicals Limited Desenex Ointment Zinc Undecenoate Ph Eur 20% w/w Except POM cases: The treatment 19th October
(t/a Fisons Consumer Health) Undecenoic Acid Ph Eur 5% w/w of mycotic superficial 1992
dermatophytoses and the relief of
itching and scaling produced by
these fungal infections.
OSL
042670066 AUergan Limited Oxysept 1-Step Neutralising Catalase HSE 5200 u Recommended Contact Lens Care 28th October
Tablet Use: For use in the Oxysept 1-Step 1992
rinaning and disinfection system to
neutralise the hydrogen peroxide
in Oxysept 1-Step Disinfecting
Solution.
0426/0070 Allergan Limited BxodnTMO-3%w/v OfloxcudnHSEO-SHw/v POM 26th October
1992
0504/0016 Wallace, Cannon and Ultra Steriflow (Pods) Sodium Dihydrogen Phosphate Except POM cases: Buffered 23rd October
Company Limited DihydrateBP 0-52% w/v tectonic solution for washing 1992
Disodium Hydrogen Phosphate injurious chemicals, foreign bodies
DodecahydnteBPl-19% w/v from the eye.
SodiumChloride BP 0-48% w/v OSL
0530/0389 Norton Healthcare Limited Cephatexin 230 ing Tablets CephatoxinBP2SOmg POM 22nd December
(I/a H. N. Norton) 1992
0530/0390 Norton Healthcare Limited Cephatoxin 500 mg Tablets CephalexinBPSOOmg POM 22nd December
(t/a H. N. Norton) 1992
1817/0017 Mafflnckrodt Medical (UK) Optirey-300 (Injection loverso! HSE 636 mg POM 30th October
636mg/ml) 1992
1817/0018 Mallinckrodt Medical (UK) Optiray-350 (Injection loversol HSE 741 mg POM 30th October
741 mg/ml) 1992
3157/0008 Combe International Limited Lanacort Crone Hydrocortisone Acetate BP 1 -000% w/w Except POM cases: Irritant 1st October
Dermatitis, Contact Allergic 1992
Dermatitis and Insect Bite
reactions.
PM
3157/0011 Combe International Limited Lanacort Ointment Hydrocortisone Acetate BP 1 -000% w/w Except POM cases: Irritant 1st October
Dermatitis, Contact Allergic 1992
Dermatitis and Insect Bite
reactions.
PM
3400/0021 Serono Laboratories (UK) Profasi 10,000 iu Chorionic Gonadotrophin HSE 10 ku POM 2nd October
1992
4416/0216 Lflgflp Ferrous Sulphate Tablets Ferrous Sulphate BP 200 mg Except POM cases: Iron-deficiency 12th January
200 mg HTIBCTnJB 1993
PM
4425/0127 Marion MerreD Dow Limited Nicabate Traudermal Patch Nicotine HSE 36-0 mg Except POM cases: Nicabate is 30th October
7 tag/Day indicated for the relief of nicotine 1992
withdrawal symptoms associated
with smoking cessation. If
possible, Nicabate should be used
with concurrent behavioural
support therapy.
PM
4425/0128 Marion Mend] Dow Limited Nicabate Transdermal Patch Nicotine HSE 78-0 mg Except POM cases: Nicabate is 30th October
14 ing/Day indicated for the relief of nicotine 1992
withdrawal symptoms associated
with smoking cessation. If
possible. Nicabate should be used
with concurrent behavioural
support therapy.
PM
4425/0129 Marion Menell Dow Limited Nicabate Transdermal Patch Nicotine HSE 114-0 mg Except POM cases: Nicabate is 30th October
21 mg/Day indicated for the relief of nicotine 1992
